This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Virginia Tech Intellectual Properties Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher J Garcia: Innovator in Mitochondrial Uncoupling Compounds
Introduction
Christopher J Garcia is an accomplished inventor based in Blacksburg, VA (US). He has made significant contributions to the field of pharmaceutical compounds, particularly those that target mitochondrial functions. His innovative work has the potential to address various health conditions, making him a notable figure in the realm of scientific research and development.
Latest Patents
Garcia holds a patent for "Oxadiazolopyrazines and oxadiazolopyridines useful as mitochondrial uncouplers." This patent describes compounds of Formula I and their pharmaceutically acceptable salts. The compounds are designed to act as selective mitochondrial protonophore uncouplers that do not affect the plasma membrane potential. They are particularly useful for treating or decreasing the risk of conditions such as cancer, obesity, type II diabetes, fatty liver disease, insulin resistance, Parkinson's disease, ischemia reperfusion injury, heart failure, non-alcoholic fatty liver disease (NALFD), and non-alcoholic steatohepatitis (NASH). Additionally, these compounds can help regulate glucose homeostasis and insulin action in patients. Notably, they also decrease the production of reactive oxygen species (ROS), which are known to contribute to age-related cell damage, thereby potentially increasing lifespan.
Career Highlights
Christopher Garcia is associated with Virginia Tech Intellectual Properties Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges through scientific discovery.
Collaborations
Garcia collaborates with notable colleagues, including Webster L Santos and Joseph Michael Salamoun. Their combined expertise enhances the research and development of groundbreaking solutions in the field of mitochondrial uncoupling.
Conclusion
Christopher J Garcia is a pioneering inventor whose work on mitochondrial uncoupling compounds holds promise for treating various health conditions. His contributions to science and medicine are significant, and his ongoing research continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
